Cardio Diagnostics announces investor conference call

PUBT · 2d ago
Cardio Diagnostics announces investor conference call
  • Cardio Diagnostics will hold an investor conference call on August 20, 2026, via webcast.
  • Discussion will cover its precision molecular strategy for cardiovascular disease prevention and early detection.
  • Updates are set to include Epi+Gen CHD and PrecisionCHD, study plans, reimbursement progress, and strategic growth initiatives.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260805019123) on August 05, 2026, and is solely responsible for the information contained therein.